These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2206790)

  • 1. Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.
    Jorge LF; Arias TD; Inaba T; Jackson PR
    Br J Clin Pharmacol; 1990 Aug; 30(2):281-5. PubMed ID: 2206790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.
    Arias TD; Jorge LF; Lee D; Barrantes R; Inaba T
    Clin Pharmacol Ther; 1988 Apr; 43(4):456-65. PubMed ID: 3356089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá.
    Arias TD; Jorge LF
    Br J Clin Pharmacol; 1989 Oct; 28(4):493-4. PubMed ID: 2590609
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the frequency distribution of debrisoquine hydroxylation deficiency in Chinese healthy Zang and Wei volunteers].
    Kuang TY; Liao XM; Wang KY; Zhang Y; Lou YQ
    Yao Xue Xue Bao; 1991; 26(4):250-4. PubMed ID: 1957669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.
    Kallio J; Lindberg R; Huupponen R; Iisalo E
    Br J Clin Pharmacol; 1988 Dec; 26(6):791-5. PubMed ID: 3242585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Population pharmacology and ethnopharmacokinetics in 3 Amerindian groups from Panama: Cuna, Ngawbe Guaymi and Teribe].
    Arias TD; Jorge LF
    Rev Med Panama; 1990 Jan; 15(1):20-6. PubMed ID: 2330419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the polymorphic oxidation of debrisoquine in the Thai population.
    Wanwimolruk S; Patamasucon P; Lee EJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):244-7. PubMed ID: 2306417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of debrisoquine metabolic phenotypes and implications for the suggested association with lung cancer risk.
    Caporaso N; Pickle LW; Bale S; Ayesh R; Hetzel M; Idle J
    Genet Epidemiol; 1989; 6(4):517-24. PubMed ID: 2777072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic debrisoquin metabolism in a Turkish population.
    Bozkurt A; Basci NE; Isimer A; Sayal A; Kayaalp SO
    Clin Pharmacol Ther; 1994 Apr; 55(4):399-401. PubMed ID: 8162666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.
    Bertilsson L; Lou YQ; Du YL; Liu Y; Kuang TY; Liao XM; Wang KY; Reviriego J; Iselius L; Sjöqvist F
    Clin Pharmacol Ther; 1992 Apr; 51(4):388-97. PubMed ID: 1345344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mephenytoin hydroxylation in the Cuna Amerindians of Panama.
    Inaba T; Jorge LF; Arias TD
    Br J Clin Pharmacol; 1988 Jan; 25(1):75-9. PubMed ID: 3370193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.
    Petersen DD; Kong AN; Jorge LF; Nebert DW; Arias TD
    Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debrisoquine and metoprolol oxidation in Zambians: a population study.
    Simooya OO; Njunju E; Hodjegan AR; Lennard MS; Tucker GT
    Pharmacogenetics; 1993 Aug; 3(4):205-8. PubMed ID: 8220440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol alpha-hydroxylation polymorphism in the San Bushmen of southern Africa.
    Sommers DK; Moncrieff J; Avenant J
    Hum Toxicol; 1989 Jan; 8(1):39-43. PubMed ID: 2714809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.
    Arias TD; Inaba T; Cooke RG; Jorge LF
    Clin Pharmacol Ther; 1988 Sep; 44(3):343-52. PubMed ID: 3416554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor.
    Nikolov IG; Chernozemsky IN; Idle JR
    IARC Sci Publ; 1991; (115):289-96. PubMed ID: 1820343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.
    Spina E; Campo GM; Calandra S; Caputi AP; Carrillo JA; Benitez J
    Pharmacol Res; 1992 Jan; 25(1):43-50. PubMed ID: 1738757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timolol metabolism and debrisoquine oxidation polymorphism: a population study.
    Lennard MS; Lewis RV; Brawn LA; Tucker GT; Ramsay LE; Jackson PR; Woods HF
    Br J Clin Pharmacol; 1989 Apr; 27(4):429-34. PubMed ID: 2719899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
    Irshaid YM; al-Hadidi HF; Latif A; Awwadi F; al-Zoubi M; Rawashdeh NM
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):301-7. PubMed ID: 9074894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.
    Siegmund W; Fengler JD; Franke G; Zschiesche M; Eike O; Eike E; Meisel P; Wulkow R
    Br J Clin Pharmacol; 1991 Oct; 32(4):467-72. PubMed ID: 1958441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.